UI Hospitals and Clinics
Participants in this research study have been diagnosed with cancer that has progressed or not responded to prior treatments containing rituximab. The purpose of this research study is to compare the effects, good and/or bad, of the experimental drug GA101 given in combination with bendamustine compared with bendamustine alone, to find which treatment is better. Approximately 360 people will take part in this study at about 80-120 study centers in the United States and other countries.
Mary Schall, 319-356-9516
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.